Rare diseases
Investigational molecules
Locations
Back to Norway14 clinical trials in Levanger, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)NorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on precision cancer medicine for rare and hard-to-treat cancers, including innovative approaches to drug repurposing and targeted therapies.
Research aims to improve treatment outcomes through personalized therapeutic approaches.
Comprehensive research into small-cell lung cancer and non-small cell lung cancer, evaluating innovative combination therapies including immunotherapy and radiotherapy.
Studies focus on improving survival rates through combined treatment modalities.
Clinical investigations of treatments for Crohn's Disease and Immune Thrombocytopenia, testing new therapeutic approaches and maintenance strategies.
Evaluating novel therapies for chronic autoimmune conditions with focus on long-term management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
